Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance (Q42688099)
Jump to navigation
Jump to search
scientific article published on 21 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance |
scientific article published on 21 May 2013 |
Statements
1 reference
Signals and noise in drug safety analyses: the incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance (English)
1 reference
Julio Rosenstock
1 reference
William T Cefalu
1 reference
Robert R Henry
1 reference
Matthew Riddle
1 reference
21 May 2013
1 reference
1 reference
1804-1806
1 reference
Identifiers
1 reference
1 reference
1 reference